Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 12 studies | 24% ± 5% | |
fibroblast | 9 studies | 22% ± 4% | |
pericyte | 9 studies | 24% ± 7% | |
B cell | 8 studies | 19% ± 3% | |
endothelial cell | 7 studies | 27% ± 10% | |
myofibroblast cell | 6 studies | 26% ± 4% | |
connective tissue cell | 6 studies | 24% ± 8% | |
epithelial cell | 5 studies | 31% ± 15% | |
neuron | 5 studies | 31% ± 16% | |
plasmacytoid dendritic cell | 4 studies | 23% ± 4% | |
pancreatic A cell | 3 studies | 39% ± 15% | |
classical monocyte | 3 studies | 24% ± 6% | |
conventional dendritic cell | 3 studies | 33% ± 13% | |
non-classical monocyte | 3 studies | 34% ± 7% | |
naive B cell | 3 studies | 20% ± 1% | |
mesothelial cell | 3 studies | 35% ± 16% | |
natural killer cell | 3 studies | 19% ± 3% | |
ciliated cell | 3 studies | 29% ± 7% | |
dendritic cell | 3 studies | 35% ± 14% | |
enteroendocrine cell | 3 studies | 27% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2312.58 | 1445 / 1445 | 100% | 35.22 | 183 / 183 |
ovary | 100% | 3074.71 | 180 / 180 | 100% | 66.92 | 430 / 430 |
thymus | 100% | 4321.44 | 653 / 653 | 100% | 45.95 | 605 / 605 |
brain | 100% | 2111.83 | 2638 / 2642 | 100% | 34.25 | 705 / 705 |
prostate | 100% | 3810.84 | 245 / 245 | 100% | 40.45 | 501 / 502 |
skin | 100% | 1697.77 | 1808 / 1809 | 100% | 27.65 | 471 / 472 |
uterus | 100% | 3172.82 | 170 / 170 | 100% | 29.60 | 457 / 459 |
pancreas | 100% | 1372.98 | 328 / 328 | 99% | 26.29 | 177 / 178 |
intestine | 100% | 2585.91 | 966 / 966 | 99% | 25.13 | 523 / 527 |
bladder | 100% | 2730.48 | 21 / 21 | 99% | 29.32 | 497 / 504 |
stomach | 100% | 1935.13 | 359 / 359 | 99% | 29.14 | 282 / 286 |
breast | 100% | 1994.57 | 458 / 459 | 99% | 28.88 | 1104 / 1118 |
lung | 100% | 1998.36 | 578 / 578 | 99% | 21.70 | 1138 / 1155 |
kidney | 100% | 2398.54 | 89 / 89 | 98% | 23.12 | 886 / 901 |
adrenal gland | 100% | 2545.79 | 258 / 258 | 98% | 29.71 | 226 / 230 |
liver | 79% | 515.58 | 178 / 226 | 80% | 11.68 | 324 / 406 |
adipose | 100% | 1778.06 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 27.74 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 46.26 | 29 / 29 |
spleen | 100% | 2889.51 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.31 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 50.60 | 1 / 1 |
blood vessel | 100% | 2627.71 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1254.47 | 846 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 1127.83 | 868 / 929 | 0% | 0 | 0 / 0 |
muscle | 84% | 606.19 | 675 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006954 | Biological process | inflammatory response |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0006935 | Biological process | chemotaxis |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0002690 | Biological process | positive regulation of leukocyte chemotaxis |
GO_0070301 | Biological process | cellular response to hydrogen peroxide |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ZNF580 |
Protein name | Zinc finger protein 580 (LDL-induced EC protein) Zinc finger protein 580 |
Synonyms | |
Description | FUNCTION: Involved in the regulation of endothelial cell proliferation and migration. Mediates H(2)O(2)-induced leukocyte chemotaxis by elevating interleukin-8 production and may play a role in inflammation. May be involved in transcriptional regulation. . |
Accessions | K7ENY2 ENST00000590190.1 ENST00000325333.10 K7ERU0 ENST00000592461.5 ENST00000545125.1 Q9UK33 ENST00000592881.1 ENST00000543039.2 K7EJ53 |